Coagulation factor XI

Coagulation factor XI

Coagulation factor XI 분자 정보

Molecule Name
Coagulation factor XI
분자 별명
Coagulation factor XI,FXI,PTA,F11
Drug Development Progress
임상 약물 수30
시판 약물 수2
최고 연구 개발 단계Approved
표적 별명
EC 3.4.21,EC:3.4.21.27,FXI,F11,PTA,Coagulation Factor XI,Plasma Thromboplastin Antecedent,EC 3.4.21.27,Factor XI,Coagualtion Factor XI
분자 배경
This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality

Coagulation factor XI 제품 목록

Species
  • Human(1)
  • Rhesus macaque(1)
Tag
  • His Tag(2)
Host
  • HEK293(2)
Conjugate
  • Unconjugated(2)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
Coagulation factor XI
Rhesus macaque Coagulation factor XI Protein, His Tag (Pro-form)
Rhesus macaque
HEK293
SDS-PAGE
ELISASPREnzyme

$465.00

50ug
Coagulation factor XI
Human Coagulation factor XI / FXI Protein, His Tag (active enzyme)
Human
HEK293
SDS-PAGE
ELISASPREnzyme

$535.00

50ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
AsundexianBAY-2433334Phase 3 ClinicalBayer AG
Atrial Fibrillation; Embolism; Hepatic Insufficiency; Ischemic Attack, Transient; Ischemic Stroke; Myocardial Infarction; Stroke; Thromboembolism
상세
CenvacibartREGN7508Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Thrombosis; Venous Thromboembolism
상세
MilvexianBMS-986177; JNJ-70033093; JNJ-3093Phase 3 ClinicalBristol-Myers Squibb Company
Acute Coronary Syndrome; Atrial Fibrillation; Contraception; Coronary Thrombosis; Embolism; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Renal Insufficiency; Stroke; Thromboembolism; Thrombosis
상세
SHR-2004SHR-2004Phase 3 ClinicalBeijing Suncadia Medicine Co Ltd
Arterial Thromboembolism; Atrial Fibrillation; Dyslipidemias; Thromboembolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis
상세
AmrecibartREGN-9933Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Venous Thromboembolism
상세
AbelacimabMAA-868; NOV-12Phase 3 ClinicalNovartis Pharma Ag
Atrial Fibrillation; Embolism; Neoplasms; Pulmonary Embolism; Stroke; Thromboembolism; Venous Thromboembolism; Venous Thrombosis
상세
EP-7041EP-7041; HSK-36273Phase 2 ClinicalExithera Pharmaceuticals Inc
Blood Coagulation Disorders; Coronavirus Disease 2019 (COVID-19); Kidney Diseases; Thrombocytopenia; Thromboembolism; Thrombosis
상세
OsocimabBAY-1213790Phase 2 ClinicalBayer AG
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism
상세
IONIS-FXIRXISIS-404071; BAY-2306001; ISIS-FXIRX; FXI-ASO; IONIS-FXIRX; ISIS-416858Phase 2 ClinicalIonis Pharmaceuticals Inc
Thrombosis; Venous Thromboembolism
상세
MK-2060MK-2060Phase 2 ClinicalMerck Sharp & Dohme Corp
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism; Thrombosis
상세
SRSD-107SRSD-107; SRSD107Phase 2 ClinicalSirius Therapeutics Inc
Arterial Thromboembolism; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Peripheral Arterial Disease; Thromboembolism; Thrombosis; Venous Thromboembolism
상세
RBD-4059RBD-4059; RBD4059; SR059; SR-059Phase 2 ClinicalSuzhou Ribo Life Science Co Ltd
Coronary Artery Disease; Coronary Disease; Kidney Failure, Chronic; Venous Thrombosis
상세
KN-060KN-060; KN060Phase 2 ClinicalSuzhou Alphamab Co Ltd
Essential Hypertension; Hypertension; Kidney Failure, Chronic; Obesity; Overweight; Thromboembolism
상세
Ir-CPIBIOX-101; Ir-CPIPhase 2 ClinicalFree University Of Brussels
Cerebral Hemorrhage
상세
FesomersenION-957943; IONIS-FXI-LRx; BAY-2976217Phase 2 ClinicalIonis Pharmaceuticals Inc
Nephrosis; Thromboembolism
상세
ONO-7269ONO-7269Phase 1 ClinicalOno Pharmaceutical Co Ltd
Cerebral Infarction
상세
BAY-1831865AB-012; BAY-1831865Phase 1 ClinicalAronora Inc
Thrombosis
상세
A-336A336; A-336Phase 1 ClinicalKlus Pharma
Thromboembolism
상세
A-186A-186Phase 1 ClinicalSichuan Kelun Pharmaceutical Co Ltd
Thromboembolism
상세
BMS-262084BMS-262084Phase 1 ClinicalBristol-Myers Squibb Company
Thrombosis
상세
ADX-626ADX-626Phase 1 ClinicalADARx Pharmaceuticals Inc
Thrombosis
상세
SBK-013SBK013; SBK-013Phase 1 ClinicalChengdu Shibeikang Biomedical Technology Co Ltd
Arterial Thromboembolism; Thromboembolism; Venous Thromboembolism
상세
XH-S002XH-S002; XHS002Phase 1 Clinical
Ischemic Attack, Transient; Stroke
상세
BMS-986209BMS-986209Phase 1 ClinicalBristol-Myers Squibb Company
상세
NIP-003NIP003; NIP-003; CRB4101; CRB-4101Phase 1 ClinicalNational Institutes Of Pharmaceutical Research And Development Co Ltd
Thromboembolism; Venous Thromboembolism; Venous Thrombosis
상세
Factor XIa Inhibitor (Bayer)Factor XIa Inhibitor (Bayer)Phase 1 ClinicalBayer AG
Blood Coagulation Disorders
상세
SKB-336SKB-336Phase 1 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Embolism; Thromboembolism
상세
SAL-0104SAL-0104; SAL0104Phase 1 ClinicalSuzhou Genemen Biotech Co Ltd
Cardiovascular Diseases; Embolism; Ischemic Attack, Transient; Myocardial Infarction; Stroke; Thrombosis; Venous Thromboembolism; Venous Thrombosis
상세
STP122GSTP-122G; STP122GPhase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Embolism and Thrombosis
상세
SHR2285SHR-2285Phase 1 ClinicalJiangsu Hengrui Medicine Co Ltd
Embolism; Thromboembolism; Thrombosis; Venous Thromboembolism
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Factor XI concentrate (factor XI deficiency), CSL BehringApprovedCsl Behring LlcAustraliaFactor XI DeficiencyCsl Behring Llc2014-07-01
Factor XI Deficiency
상세
Human coagulation Factor XI (LFB)ApprovedLfb Biotechnologies SasHemolevenEUFactor XI DeficiencyLfb Biotechnologies Sas1999-07-01
Factor XI Deficiency
상세
Customer Reviews